Trial
NCT03553615
Open-label Pilot Clinical Trial of Oral Ivermectin to Treat Atopic Dermatitis
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Stanford University
Collaborators
—
Condition
Atopic Dermatitis
Intervention
Ivermectin Pill
Why stopped
Limited clinical capacity
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-12-02